A clinical trial to assess the role of repetitive Transcranial Magnetic Stimulation (rTMS) in Smoking Cessation in an Egyptian Sample

Ain Shams University Institute of Psychiatry0 个研究点目标入组 54 人开始时间: 2019年9月29日最近更新: 2023年5月29日

试验速览

暂无简介。

•Both genders
•Ages 18 to 60 years.
•Current smokers or waterpipe users.
•Meet criteria for nicotine dependence as determined by the FTND.
•Willing to provide informed consent.
•Able to comply with protocol requirements and willing to complete all study procedures.

•Current dependence, defined by ICD-10 criteria, on any psychoactive substances other than nicotine or caffeine or received substance use treatment within past 30 days
•History of serious mental illness such as: Bipolar disorder, Psychotic illness, Major Depression with psychotic features and other psychiatric illness such as OCD or eating disorders
•Contraindication to rTMS (history of neurological disorder or seizure, increased intracranial pressure, brain surgery, or History of autoimmune, endocrine, viral, or vascular disorder affecting the brain.
•History or MRI evidence of neurological disorder that would lead to local or diffuse brain lesions or significant physical impairment.
•Unstable cardiac disease, uncontrolled hypertension, severe renal or liver insufficiency.

发起方

Ain Shams University Institute of Psychiatry